Narayana Hrudaya

INR
1,932.10
28.3 (1.49%)
BSENSE

Aug 28, 03:30 PM

BSE+NSE Vol: 2.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.38 lacs (-32.05%) Volume

Shareholding (Jun 2026)

FII

9.40%

Held by 223 FIIs

DII

9.05%

Held by 21 DIIs

Promoter

63.27%

Why is Narayana Hrudayalaya Ltd falling/rising?

29-Aug-2026

As of 28-Aug, Narayana Hrudayalaya Ltd's stock price is rising to 1,931.65, supported by strong fundamentals and increased investor participation. The stock has outperformed the Sensex and shows positive trends, indicating growing confidence among investors.

As of 28-Aug, Narayana Hrudayalaya Ltd's stock price is rising, currently at 1,931.65, reflecting an increase of 27.7 points or 1.45%. This upward movement is supported by several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 6.39% compared to the Sensex's decline of 0.36%. Additionally, the stock has shown a consecutive gain over the last two days, with a total return of 2.49% during this period.<BR><BR>Investor participation has also increased, as evidenced by a delivery volume of 2.46 lacs on August 27, which is a 37.24% rise compared to the five-day average. This indicates growing interest and confidence among investors. Furthermore, the stock is trading above its 5-day, 20-day, 100-day, and 200-day moving averages, suggesting a positive trend, although it remains below the 50-day moving average.<BR><BR>The company's strong fundamentals contribute to this positive sentiment. It boasts a high return on capital employed (ROCE) of 24.32%, a low debt to EBITDA ratio of 3.62 times, and impressive growth in net sales and operating profit, with annual growth rates of 24.37% and 40.47%, respectively. The stock is also trading at a discount compared to its peers' average historical valuations, which enhances its attractiveness to investors.<BR><BR>Overall, the combination of strong recent performance, increased investor participation, and solid financial fundamentals is driving the rise in Narayana Hrudayalaya Ltd's stock price.

View full answer

Who are in the management team of Narayana Hrudaya?

14-Aug-2026

The management team of Narayana Hrudaya includes key members such as Devi Prasad Shetty (Chairman), Viren Shetty (Executive Vice Chairman), and Emmanuel Rupert (Managing Director & Group CEO), along with several independent directors and a Company Secretary. This diverse team provides strategic direction and governance for the organization.

The management team of Narayana Hrudaya includes the following key members:<BR><BR>1. **Devi Prasad Shetty** - Chairman & Wholetime Director<BR>2. **Viren Shetty** - Executive Vice Chairman<BR>3. **Emmanuel Rupert** - Managing Director & Group CEO<BR>4. **Kiran Mazumdar Shaw** - Director<BR>5. **Dinesh Krishna Swamy** - Independent Director<BR>6. **B Muthuraman** - Independent Director<BR>7. **B N Subramanya** - Independent Director<BR>8. **Arun Seth** - Independent Director<BR>9. **Terri Smith Bresenham** - Independent Director<BR>10. **Nachiket Mor** - Independent Director<BR>11. **Shankar Arunachalam** - Independent Director<BR>12. **Naveen Tewari** - Independent Director<BR>13. **Sridhar S** - Company Secretary & Compliance Officer<BR><BR>This diverse team brings a wealth of experience and expertise to the organization, contributing to its strategic direction and governance.

View full answer

What does Narayana Hrudaya do?

14-Aug-2026

Narayana Hrudayalaya Ltd is a mid-cap company providing medical and healthcare services, founded by Dr. Devi Prasad Shetty in 2000. As of June 2026, it reported net sales of ₹2,684 Cr and a net profit of ₹207 Cr, with a market cap of ₹37,582 Cr.

Overview: <BR>Narayana Hrudayalaya Ltd is primarily engaged in rendering medical and healthcare services within the hospital industry and operates as a mid-cap company.<BR><BR>History: <BR>The company was incorporated on 19 July 2000 by Dr. Devi Prasad Shetty. The latest quarterly results reported are for June 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Net Sales: 2,684 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 207 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 37,582 Cr (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 43.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.25% <BR>Debt-Equity: 0.73 <BR>Return on Equity: 18.79% <BR>Price to Book: 8.27<BR><BR>Contact Details: <BR>Address: No 258/A Bommasandra Indl Area, Anekal Taluq Bengaluru Karnataka : 560099 <BR>Tel: 91-80-71222802 <BR>Email: investorrelations@narayanahealth.or <BR>Website: http://www.narayanahealth.org

View full answer

Who are the peers of the Narayana Hrudaya?

14-Aug-2026

Narayana Hrudaya's peers include Max Healthcare, Aster DM Quality, Fortis Health, Global Health, Krishna Institute, Dr. Agarwal's Health, Rainbow Children, and Health.Global. It has good management risk and excellent growth, with a 1-year return of -0.17%, better than Max Healthcare but worse than Aster DM Quality, which has the highest return at 34.49%.

Peers: The peers of Narayana Hrudaya are Max Healthcare, Aster DM Quality, Fortis Health., Global Health, Krishna Institu., Dr Agarwal's Hea, Rainbow Child., and Health.Global.<BR><BR>Quality Snapshot: Excellent management risk is observed at Global Health and the rest. Good management risk is found at Aster DM Quality, Krishna Institu., Narayana Hrudaya, Dr Agarwal's Hea, and Rainbow Child., while Average management risk is present at Max Healthcare, Fortis Health., and Health.Global. Growth is excellent at Narayana Hrudaya and Max Healthcare, while good growth is noted at Fortis Health., Global Health, Dr Agarwal's Hea, and Krishna Institu., with below average growth at Aster DM Quality and Rainbow Child. Capital structure is excellent at Max Healthcare and Global Health, good at Narayana Hrudaya, Fortis Health., Krishna Institu., Dr Agarwal's Hea, and Rainbow Child., and average at Aster DM Quality and Health.Global.<BR><BR>Return Snapshot: Aster DM Quality has the highest 1-year return at 34.49%, while Max Healthcare has the lowest at -20.39%. Narayana Hrudaya's 1-year return is -0.17%, which is better than Max Healthcare but worse than Aster DM Quality. Additionally, Health.Global and Max Healthcare have negative six-month returns.

View full answer

How big is Narayana Hrudaya?

14-Aug-2026

As of 14th August, Narayana Hrudayalaya Ltd has a market capitalization of 37,543.12 Cr, with recent net sales of 9,072.40 Cr and net profit of 816.13 Cr over the last four quarters.

As of 14th August, <BR><BR>Market Cap: Narayana Hrudayalaya Ltd has a market capitalization of 37,543.12 Cr, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 9,072.40 Cr, while the sum of Net Profit for the same period is 816.13 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2026, with Shareholder's Funds amounting to 4,537.26 Cr and Total Assets totaling 12,463.18 Cr.

View full answer

Should I buy, sell or hold Narayana Hrudayalaya Ltd?

04-Aug-2026

When is the next results date for Narayana Hrudayalaya Ltd?

28-Jul-2026

The next results date for Narayana Hrudayalaya Ltd is July 31, 2026.

The next results date for Narayana Hrudayalaya Ltd is scheduled for July 31, 2026.

View full answer

Are Narayana Hrudayalaya Ltd latest results good or bad?

23-May-2026

Narayana Hrudayalaya Ltd's latest results show strong revenue growth with a net profit increase of 76.70% QoQ, but declining operating margins raise concerns about profitability, leading to a 3.85% drop in stock price post-announcement. Overall, while revenue performance is positive, margin compression suggests potential challenges ahead.

Narayana Hrudayalaya Ltd's latest results present a mixed picture. On one hand, the company achieved a consolidated net profit of ₹223.88 crore, which is a significant increase of 76.70% quarter-on-quarter (QoQ) and 13.52% year-on-year (YoY). Additionally, net sales reached ₹2,593.81 crore, reflecting a strong QoQ growth of 20.58% and an impressive YoY increase of 75.80%. <BR><BR>However, there are concerns regarding profitability metrics. The operating margin (excluding other income) declined to 19.66%, down 458 basis points from the previous quarter and the same period last year. This indicates rising cost pressures that have impacted profitability despite robust revenue growth. The profit after tax (PAT) margin improved sequentially to 8.79% but is still below the previous year's figure of 13.30%.<BR><BR>The stock market reacted negatively to the results, with a decline of 3.85% following the announcement, reflecting investor concerns about the margin deterioration. While the long-term performance of the stock has been strong, recent trends indicate challenges that could affect future performance.<BR><BR>In summary, while the revenue growth is commendable, the significant margin compression raises questions about the company's cost management and overall profitability in the near term.

View full answer

Is Narayana Hrudaya technically bullish or bearish?

18-Nov-2025

As of November 17, 2025, Narayana Hrudaya's trend is bullish, supported by strong MACD and Bollinger Bands indicators, although a bearish KST signal on the weekly chart slightly tempers the overall outlook.

As of 17 November 2025, the technical trend for Narayana Hrudaya has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate a bullish trend in both time frames. Daily moving averages are bullish, reinforcing the upward momentum. However, the KST shows a bearish signal on the weekly, which slightly tempers the overall bullish outlook. The Dow Theory reflects a mildly bullish stance on both weekly and monthly charts. Overall, the strength of the bullish trend is supported by multiple indicators, despite some mixed signals in the KST.

View full answer

How has been the historical performance of Narayana Hrudaya?

15-Nov-2025

Narayana Hrudaya has shown strong financial growth, with net sales increasing from 2,582.35 crore in March 2021 to 5,482.98 crore in March 2025, and profit before tax improving from a loss of 49.23 crore to a profit of 935.54 crore during the same period. The company's total assets rose significantly, indicating robust expansion and improved profitability.

Answer:<BR>The historical performance of Narayana Hrudaya shows a consistent growth trajectory in net sales, which increased from 2,582.35 crore in March 2021 to 5,482.98 crore in March 2025. The total operating income followed a similar trend, reaching 5,482.98 crore in March 2025, up from 2,582.35 crore in March 2021. Operating profit (PBDIT) also saw significant growth, climbing to 1,368.43 crore in March 2025 from 210.29 crore in March 2021. Profit before tax improved from a loss of 49.23 crore in March 2021 to a profit of 935.54 crore in March 2025, while profit after tax increased to 789.82 crore in March 2025 from a loss of 7.45 crore in March 2021. The company's total assets rose from 2,889.06 crore in March 2020 to 7,257.31 crore in March 2025, indicating strong asset growth. Total liabilities also increased, reaching 7,257.31 crore in March 2025, up from 2,889.06 crore in March 2020. Cash flow from operating activities was robust, amounting to 985 crore in March 2025, although cash flow from investing activities showed a significant outflow of 1,324 crore. The company maintained a positive net cash inflow of 205 crore in March 2025.<BR><BR>Breakdown:<BR>Narayana Hrudaya's financial performance over the years reflects a strong upward trend in key metrics. Net sales surged from 2,582.35 crore in March 2021 to 5,482.98 crore in March 2025, while total operating income mirrored this growth, reaching the same figure. The operating profit (PBDIT) increased significantly, from 210.29 crore in March 2021 to 1,368.43 crore in March 2025, showcasing improved operational efficiency. Profit before tax transitioned from a loss of 49.23 crore in March 2021 to a profit of 935.54 crore in March 2025, and profit after tax followed suit, rising to 789.82 crore from a loss of 7.45 crore. The total assets of the company expanded from 2,889.06 crore in March 2020 to 7,257.31 crore in March 2025, indicating substantial growth in resources. Total liabilities also increased, reflecting the company's expansion strategy. Cash flow from operating activities remained strong at 985 crore in March 2025, although the company experienced a notable outflow in cash flow from investing activities. Overall, Narayana Hrudaya has demonstrated robust growth and improved profitability over the years.

View full answer

Who are the top shareholders of the Narayana Hrudaya?

17-Jul-2025

The top shareholders of Narayana Hrudaya include Shakuntala Shetty with 35.38%, 22 mutual fund schemes holding 5.71%, 217 foreign institutional investors with 9.66%, and Kiran Mazumdar Shaw as the highest public shareholder at 2.3%. Individual investors collectively own 11.47% of the shares.

The top shareholders of Narayana Hrudaya include the promoters, with Shakuntala Shetty being the largest individual shareholder, holding 35.38% of the company. There are also 22 mutual fund schemes collectively holding 5.71% and 217 foreign institutional investors (FIIs) with a combined holding of 9.66%. Additionally, Kiran Mazumdar Shaw is noted as the highest public shareholder, owning 2.3%. Individual investors collectively hold 11.47% of the shares.

View full answer

Is Narayana Hrudaya overvalued or undervalued?

01-Jul-2025

As of June 30, 2025, Narayana Hrudaya is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 55.72 and an EV to EBITDA of 35.36, despite a strong year-to-date return of 71.05%, suggesting caution for investors.

As of 30 June 2025, the valuation grade for Narayana Hrudaya has moved from very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 55.72, an EV to EBITDA of 35.36, and a PEG ratio of 46.64. In comparison, Apollo Hospitals, which is rated attractive, has a PE ratio of 71.96 and an EV to EBITDA of 36.11, while Fortis Health, also expensive, has a PE ratio of 71.25 and an EV to EBITDA of 38.89.<BR><BR>Despite the recent stock performance, which has outpaced the Sensex with a year-to-date return of 71.05% compared to the Sensex's 7.00%, the high valuation ratios indicate that Narayana Hrudaya is trading at a premium relative to its peers. Therefore, investors should approach this stock with caution given its current overvaluation status.

View full answer

Has Narayana Hrudaya declared dividend?

06-Jun-2025

Narayana Hrudayalaya Ltd has declared a 40% dividend, amounting to ₹4 per share, with an ex-date of August 2, 2024. The company has shown strong price appreciation over various periods, with total returns reaching 515.5% over the past five years.

Narayana Hrudayalaya Ltd has declared a 40% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 40%<BR>- Amount per share: 4<BR>- Ex-date: 02 Aug 24<BR><BR>Dividend Yield: 0.23%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 30.76%, with a dividend return of 0%, resulting in a total return of 30.76%.<BR><BR>Over the past year, the price return stood at 40.91%, with a dividend return of 0.32%, leading to a total return of 41.23%.<BR><BR>In the 2-year period, the price return was 94.69%, while the dividend return was 0.65%, culminating in a total return of 95.34%.<BR><BR>For the 3-year period, the price return reached 168.32%, with a dividend return of 1.18%, resulting in a total return of 169.5%.<BR><BR>In the last 4 years, the price return was 254.6%, with a dividend return of 1.55%, leading to a total return of 256.15%.<BR><BR>Over the past 5 years, the price return was 512.7%, with a dividend return of 2.80%, resulting in a total return of 515.5%.<BR><BR>Overall, Narayana Hrudayalaya Ltd has declared a significant dividend, and the total returns over various periods indicate strong price appreciation, particularly over the longer term, despite relatively low dividend returns.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROCE of 24.32%

 
2

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 3.62 times

 
3

Healthy long term growth as Net Sales has grown by an annual rate of 24.37% and Operating profit at 40.47%

 
4

Flat results in Jun 26

5

With ROCE of 14.9, it has a Attractive valuation with a 5.4 Enterprise value to Capital Employed

6

Falling Participation by Institutional Investors

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 39,440 Cr (Mid Cap)

stock-summary
P/E

46.00

stock-summary
Industry P/E

68

stock-summary
Dividend Yield

0.24%

stock-summary
Debt Equity

0.73

stock-summary
Return on Equity

18.79%

stock-summary
Price to Book

8.59

Revenue and Profits:
Net Sales:
2,684 Cr
(Quarterly Results - Jun 2026)
Net Profit:
207 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.24%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.62%
0.24%
0.86%
6 Months
5.53%
0.25%
5.78%
1 Year
10.15%
0.25%
10.4%
2 Years
51.64%
0.65%
52.29%
3 Years
88.08%
1.19%
89.27%
4 Years
181.52%
2.23%
183.75%
5 Years
277.55%
3.17%
280.72%

Latest dividend: 4.5 per share ex-dividend date: Jul-17-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Narayana Hrudayalaya Ltd. - Other General Purpose

27-Nov-2019 | Source : NSE

Narayana Hrudayalaya Ltd. has informed the Exchange regarding Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015

Narayana Hrudayalaya Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

22-Nov-2019 | Source : NSE

Narayana Hrudayalaya Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Narayana Hrudayalaya Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

14-Nov-2019 | Source : NSE

Narayana Hrudayalaya Ltd. has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Narayana Hrudayalaya Ltd has declared 45% dividend, ex-date: 17 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
24.37%
EBIT Growth (5y)
40.47%
EBIT to Interest (avg)
7.66
Debt to EBITDA (avg)
1.55
Net Debt to Equity (avg)
0.73
Sales to Capital Employed (avg)
1.25
Tax Ratio
17.70%
Dividend Payout Ratio
11.42%
Pledged Shares
0
Institutional Holding
18.46%
ROCE (avg)
25.10%
ROE (avg)
23.89%

Valuation key factors

Factor
Value
P/E Ratio
46
Industry P/E
68
Price to Book Value
8.70
EV to EBIT
34.78
EV to EBITDA
24.45
EV to Capital Employed
5.45
EV to Sales
4.71
PEG Ratio
5.01
Dividend Yield
0.23%
ROCE (Latest)
14.89%
ROE (Latest)
18.79%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 26 Schemes (7.34%)

FIIs

Held by 223 FIIs (9.4%)

Promoter with highest holding

Shakuntala Shetty (34.8%)

Highest Public shareholder

Mirae Asset Infrastructure Fund (3.36%)

Individual Investors Holdings

10.93%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 3.46% vs 20.58% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -7.46% vs 76.70% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,683.63",
          "val2": "2,593.81",
          "chgp": "3.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "469.70",
          "val2": "509.98",
          "chgp": "-7.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "86.80",
          "val2": "91.29",
          "chgp": "-4.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-4.06",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "207.18",
          "val2": "223.88",
          "chgp": "-7.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.50%",
          "val2": "19.66%",
          "chgp": "-2.16%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 17.89% vs 5.29% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 13.75% vs -2.56% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,151.06",
          "val2": "2,672.95",
          "chgp": "17.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "739.45",
          "val2": "611.25",
          "chgp": "20.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "87.42",
          "val2": "69.14",
          "chgp": "26.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.86",
          "val2": "0.35",
          "chgp": "145.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "455.02",
          "val2": "400.01",
          "chgp": "13.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.47%",
          "val2": "22.87%",
          "chgp": "0.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 32.31% vs 7.09% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1.89% vs -0.94% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,302.23",
          "val2": "4,007.54",
          "chgp": "32.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,106.68",
          "val2": "918.67",
          "chgp": "20.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "152.45",
          "val2": "105.72",
          "chgp": "44.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-51.38",
          "val2": "-0.24",
          "chgp": "-21,308.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "581.72",
          "val2": "592.95",
          "chgp": "-1.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.87%",
          "val2": "22.92%",
          "chgp": "-2.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 44.01% vs 12.12% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 1.95% vs 0.11% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,896.04",
          "val2": "5,482.98",
          "chgp": "44.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,616.67",
          "val2": "1,276.39",
          "chgp": "26.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "243.74",
          "val2": "146.41",
          "chgp": "66.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-55.43",
          "val2": "-7.55",
          "chgp": "-634.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "805.60",
          "val2": "790.16",
          "chgp": "1.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.47%",
          "val2": "23.28%",
          "chgp": "-2.81%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
2,683.63
2,593.81
3.46%
Operating Profit (PBDIT) excl Other Income
469.70
509.98
-7.90%
Interest
86.80
91.29
-4.92%
Exceptional Items
0.00
-4.06
100.00%
Consolidate Net Profit
207.18
223.88
-7.46%
Operating Profit Margin (Excl OI)
17.50%
19.66%
-2.16%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 3.46% vs 20.58% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -7.46% vs 76.70% in Mar 2026

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
3,151.06
2,672.95
17.89%
Operating Profit (PBDIT) excl Other Income
739.45
611.25
20.97%
Interest
87.42
69.14
26.44%
Exceptional Items
0.86
0.35
145.71%
Consolidate Net Profit
455.02
400.01
13.75%
Operating Profit Margin (Excl OI)
23.47%
22.87%
0.60%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 17.89% vs 5.29% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 13.75% vs -2.56% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
5,302.23
4,007.54
32.31%
Operating Profit (PBDIT) excl Other Income
1,106.68
918.67
20.47%
Interest
152.45
105.72
44.20%
Exceptional Items
-51.38
-0.24
-21,308.33%
Consolidate Net Profit
581.72
592.95
-1.89%
Operating Profit Margin (Excl OI)
20.87%
22.92%
-2.05%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 32.31% vs 7.09% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -1.89% vs -0.94% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
7,896.04
5,482.98
44.01%
Operating Profit (PBDIT) excl Other Income
1,616.67
1,276.39
26.66%
Interest
243.74
146.41
66.48%
Exceptional Items
-55.43
-7.55
-634.17%
Consolidate Net Profit
805.60
790.16
1.95%
Operating Profit Margin (Excl OI)
20.47%
23.28%
-2.81%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 44.01% vs 12.12% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 1.95% vs 0.11% in Mar 2025

stock-summaryCompany CV
About Narayana Hrudayalaya Ltd stock-summary
stock-summary
Narayana Hrudayalaya Ltd
Mid Cap
Hospital
Narayana Hrudayalaya Limited was incorporated on 19 July 2000 by Dr. Devi Prasad Shetty as its Founder. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispeciality, and super speciality hospitals spread across multiple locations. The Company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals.
Company Coordinates stock-summary
Company Details
No 258/A Bommasandra Indl Area, Anekal Taluq Bengaluru Karnataka : 560099
stock-summary
Tel: 91-80-71222802
stock-summary
investorrelations@narayanahealth.or
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad